Huang Y, Gil D W, Vanscheeuwijck P, Stamer W D, Regan J W
Department of Physiology, College of Pharmacy, University of Arizona, Tucson 85721, USA.
Invest Ophthalmol Vis Sci. 1995 Dec;36(13):2729-39.
To develop antibodies that selectively recognize each of the alpha 2-adrenergic receptor (AR) subtypes and to determine the expression and localization of these subtypes in the anterior segment of the human eye.
Recent studies have shown that there are three subtypes of the alpha 2-ARs, termed alpha 2-C10 (alpha 2A), alpha 2-C2 (alpha 2B), and alpha 2-C4 (alpha 2C). Polymerase chain reaction was used to amplify portions of these receptors fused (in-frame) to a cDNA encoding glutathione-S-transferase (GST). The expressed fusion proteins were used to immunize chickens, and antibodies were generated. Immunofluorescence microscopy was used to localize the alpha 2-AR subtypes in sections of human and rabbit ciliary body. Polymerase chain reaction and dot blot hybridization were used to determine which subtypes were present in RNA from primary cultures of human nonpigmented epithelium (NPE) and rabbit iris-ciliary body (ICB).
Immunofluorescence microscopy of COS cells transfected with the alpha 2-AR subtypes showed that the antibodies raised against the GST-receptor fusion proteins specifically recognized their respective receptor subtypes. In the human ciliary body, alpha 2 B and alpha 2C immunoreactivity were present in the NPE and ciliary muscle. In the rabbit ciliary body, alpha 2A immunoreactivity also was present. Polymerase chain reaction and dot blot hybridization indicated that RNA encoding the alpha 2B and alpha 2C subtypes was present in human NPE and that RNA encoding all three subtypes was present in the rabbit ICB.
Multiple alpha 2-adrenergic subtypes are expressed in the ciliary body. In the human, alpha 2B and alpha 2C predominate, whereas all three are present in the rabbit. This could be important with respect to animal models of glaucoma and to the development of drugs for lowering intraocular pressure.
研发能够选择性识别各α2 -肾上腺素能受体(AR)亚型的抗体,并确定这些亚型在人眼前节中的表达及定位。
近期研究表明,α2 -ARs存在三种亚型,分别称为α2 -C10(α2A)、α2 -C2(α2B)和α2 -C4(α2C)。采用聚合酶链反应扩增这些受体与编码谷胱甘肽 - S -转移酶(GST)的cDNA融合(读框内)的部分片段。将表达的融合蛋白用于免疫鸡,从而产生抗体。利用免疫荧光显微镜对人和兔睫状体切片中的α2 -AR亚型进行定位。采用聚合酶链反应和斑点印迹杂交法确定人非色素上皮细胞(NPE)原代培养物及兔虹膜 -睫状体(ICB)RNA中存在哪些亚型。
用α2 -AR亚型转染的COS细胞的免疫荧光显微镜检查显示,针对GST -受体融合蛋白产生的抗体能特异性识别各自的受体亚型。在人睫状体中,NPE和睫状肌存在α2B和α2C免疫反应性。在兔睫状体中,也存在α2A免疫反应性。聚合酶链反应和斑点印迹杂交表明,人NPE中存在编码α2B和α2C亚型的RNA,兔ICB中存在编码所有三种亚型的RNA。
睫状体中表达多种α2 -肾上腺素能亚型。在人中,以α2B和α2C为主,而兔中三种亚型均有表达。这对于青光眼动物模型及降低眼压药物的研发可能具有重要意义。